Loading...

Henry Schein, Inc.

HSICNASDAQ
HealthcareMedical - Distribution
$66.24
$-0.34(-0.51%)

Henry Schein, Inc. (HSIC) Stock Overview

Explore Henry Schein, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
2.71%
2.71%
Profit Growth
$3.08
6.25%
EPS Growth
$3.08
3.14%
Operating Margin
5.10%
0.98%
ROE
11.14%
6.25%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0

Price Targets

Low$67.00
Average$77.67
High$92.00

Company Profile

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

CEO

Mr. Stanley M. Bergman C.P.A.

Employees

25,000

Headquarters

135 Duryea Road, Melville, NY

Founded

1995

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.